Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
54.08 USD | +1.10% | +4.10% | -26.90% |
May. 23 | U.S. FDA advisers back approval for Guardant's cancer test | RE |
May. 21 | Exact Sciences Says Court Allows Patent Lawsuit Against Geneoscopy to Proceed | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.90% | 9.98B | |
-16.78% | 2.75B | |
-17.50% | 2.07B | |
-24.25% | 1.59B | |
+64.58% | 1.43B | |
+31.92% | 824M | |
-5.02% | 733M | |
-29.59% | 508M | |
+0.20% | 296M | |
-28.40% | 158M |
- Stock Market
- Equities
- EXAS Stock
- News Exact Sciences Corporation
- Transcript : Exact Sciences Corporation, Q1 2024 Earnings Call, May 08, 2024